Foresite Capital Management Iv, LLC Aclaris Therapeutics, Inc. Transaction History

Foresite Capital Management Iv, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$10.16 - $17.08 $924,560 - $1.55 Million	-91,000 Reduced 3.14%	2,808,034 $39.2 Million
Q1 2022 May 13, 2022	SELL	$9.74 - $17.92 $4.87 Million - $8.96 Million	-500,000 Reduced 14.71%	2,899,034 $50 Million
Q1 2021 May 17, 2021	BUY	$5.86 - $27.73 $14.3 Million - $67.9 Million	2,447,650 Added 257.27%	3,399,034 $85.7 Million
Q4 2020 Feb 16, 2021	BUY	$2.65 - $7.61 $2.14 Million - $6.14 Million	806,510 Added 556.7%	951,384 $6.16 Million
Q3 2020 Nov 13, 2020	BUY	$1.5 - $2.71 $217,311 - $392,608	144,874 New	144,874 $372,000
Q1 2019 May 14, 2019	SELL	$5.63 - $7.84 $4.21 Million - $5.87 Million	-748,132 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$6.3 - $15.4 $1.38 Million - $3.37 Million	218,581 Added 41.28%	748,132 $5.53 Million
Q2 2018 Aug 14, 2018	BUY	$16.46 - $20.33 $1.65 Million - $2.03 Million	100,000 Added 23.28%	529,551 $10.6 Million
Q1 2018 May 15, 2018	BUY	$17.08 - $25.64 $3.03 Million - $4.55 Million	177,615 Added 70.5%	429,551 $7.53 Million
Q4 2017 Feb 13, 2018	BUY	$21.47 - $27.8 $5.41 Million - $7 Million	251,936	251,936 $6.21 Million

50.7M

30.6K

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $195M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

Get notified when there are updates to the investment portfolio of Foresite Capital Management Iv, LLC, based on Form 13F filings with the SEC.

Stay updated on Foresite Capital Management Iv, LLC with notifications on news.